Safety concerns and health benefits associated with oral contraception

  • Department of Obstetrics/Gynecology, Baystate Medical Center, Springfield, MA 01199, USA. rtb@bhs.org
  • Sylvester Comprehensive Cancer Center ROR

American Journal of Obstetrics and Gynecology, 190(4 Suppl), S5-S22

DOI 10.1016/j.ajog.2004.01.061 PMID 15105794

Abstract

Since the introduction of hormonal contraceptives in the 1960s, there have been a variety of both health benefits and safety concerns attributed to their use. In most instances, the noncontraceptive benefits of oral contraceptives (OCs) outweigh the potential cardiovascular risks. In fact, the probability of a patient experiencing a cardiovascular event while taking a low-dose OC is very low. However, smoking, hypertension, obesity, and diabetes are risk factors that must be taken into account when prescribing OCs. The neoplastic effects of hormonal contraceptives have been extensively studied, and recent meta-analyses indicate that there is a reduction in the risk of endometrial and ovarian cancer, a possible small increase in the risk for breast and cervical cancer, and an increased risk of liver cancer. Finally, many women will experience noncontraceptive health benefits with OCs that expand far beyond pregnancy prevention. Some of these benefits include reduction in menstrual-related symptoms, fewer ectopic pregnancies, a possible increase in bone density, and possible protection against pelvic inflammatory disease.

Topics

oral contraceptive safety cardiovascular risk cancer risk, hormonal contraceptive noncontraceptive health benefits review, oral contraceptive breast cancer endometrial cancer risk, Burkman oral contraceptive safety concerns benefits, low-dose oral contraceptive cardiovascular event risk, OC use ovarian cancer risk reduction meta-analysis, hormonal contraception bone density pelvic inflammatory disease, oral contraceptive menstrual symptom management benefits, contraceptive pill smoking hypertension obesity risk factors, hormonal contraceptive neoplastic effects comprehensive review
PMID 15105794 15105794 DOI 10.1016/j.ajog.2004.01.061 10.1016/j.ajog.2004.01.061

Cite this article

Burkman, R., Schlesselman, J. J., & Zieman, M. (2004). Safety concerns and health benefits associated with oral contraception. *American journal of obstetrics and gynecology*, *190*(4 Suppl), S5-S22. https://doi.org/10.1016/j.ajog.2004.01.061

Related articles